ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Type-1 Diabetes Treatment Market Insights, Forecast to 2030
Published Date: December 2024
|
Report Code: QYRE-Auto-18I2851
Home | Market Reports | Health| Health Conditions| Endocrine Conditions
Global Type 1 Diabetes Treatment Market Insights Forecast to 2028
BUY CHAPTERS

Global Type-1 Diabetes Treatment Market Insights, Forecast to 2030

Code: QYRE-Auto-18I2851
Report
December 2024
Pages:107
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Astellas Pharma
Merck
Eli Lilly
Sanofi
Astrazeneca plc
Boehringer Ingelheim GmbH
Novartis
Pfizer Inc
Abbott Laboratories
MannKind Corporation
Braun Melsungen AG
MacroGenics Inc
Novo Nordisk

Type-1 Diabetes Treatment Market Size

The global Type-1 Diabetes Treatment market is projected to grow from US$ 5401.7 million in 2024 to US$ 7034.4 million by 2030, at a Compound Annual Growth Rate (CAGR) of 4.5% during the forecast period.

Type-1 Diabetes Treatment Market

Type-1 Diabetes Treatment Market

Type-1 diabetes accounts for 5%–10% of all diabetes cases worldwide. Failure to produce insulin is the cause of this type of diabetes. 
Market Analysis and Insights: Global Type-1 Diabetes Treatment Market
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Covers:
This report presents an overview of global market for Type-1 Diabetes Treatment market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Type-1 Diabetes Treatment, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Type-1 Diabetes Treatment, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Type-1 Diabetes Treatment revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Type-1 Diabetes Treatment market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Type-1 Diabetes Treatment revenue, projected growth trends, production technology, application and end-user industry.
Market Segmentation

Scope of Type-1 Diabetes Treatment Market Report

Report Metric Details
Report Name Type-1 Diabetes Treatment Market
Accounted market size in 2024 US$ 5401.7 million
Forecasted market size in 2030 US$ 7034.4 million
CAGR 4.5
Base Year 2024
Forecasted years 2025 - 2030
Segment by Type
  • Rapid-Acting Insulin
  • Short-Acting Insulin
  • Others
Segment by Application
  • Hospitals & Clinics
  • Academic & Research Institutes
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Astellas Pharma, Merck, Eli Lilly, Novo Nordisk, Sanofi, AstraZeneca, Boehringer Ingelheim GmbH, Novartis, Pfizer Inc., Abbott Laboratories, Mannkind Corporation, Braun Melsungen AG, Macrogenics, Inc.
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Revenue of Type-1 Diabetes Treatment in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Type-1 Diabetes Treatment companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
  • Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
  • Chapter 8: China by Type, and by Application, revenue for each segment.
  • Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
  • Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
  • Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Type-1 Diabetes Treatment revenue, gross margin, and recent development, etc.
  • Chapter 12: Analyst's Viewpoints/Conclusions

FAQ for this report

How fast is Type-1 Diabetes Treatment Market growing?

Ans: The Type-1 Diabetes Treatment Market witnessing a CAGR of 4.5 during the forecast period 2025-2030.

What is the Type-1 Diabetes Treatment Market size in 2030?

Ans: The Type-1 Diabetes Treatment Market size in 2030 will be US$ 7034.4 million.

Who are the main players in the Type-1 Diabetes Treatment Market report?

Ans: The main players in the Type-1 Diabetes Treatment Market are Astellas Pharma, Merck, Eli Lilly, Novo Nordisk, Sanofi, AstraZeneca, Boehringer Ingelheim GmbH, Novartis, Pfizer Inc., Abbott Laboratories, Mannkind Corporation, Braun Melsungen AG, Macrogenics, Inc.

What are the Application segmentation covered in the Type-1 Diabetes Treatment Market report?

Ans: The Applications covered in the Type-1 Diabetes Treatment Market report are Hospitals & Clinics, Academic & Research Institutes

What are the Type segmentation covered in the Type-1 Diabetes Treatment Market report?

Ans: The Types covered in the Type-1 Diabetes Treatment Market report are Rapid-Acting Insulin, Short-Acting Insulin, Others

Recommended Reports

Diabetes & Metabolic

Chronic Disease Drugs

Neurological & Autoimmune

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Type-1 Diabetes Treatment Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Rapid-Acting Insulin
1.2.3 Short-Acting Insulin
1.2.4 Others
1.3 Market by Application
1.3.1 Global Type-1 Diabetes Treatment Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Hospitals & Clinics
1.3.3 Academic & Research Institutes
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Type-1 Diabetes Treatment Market Perspective (2019-2030)
2.2 Global Type-1 Diabetes Treatment Growth Trends by Region
2.2.1 Type-1 Diabetes Treatment Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Type-1 Diabetes Treatment Historic Market Size by Region (2019-2024)
2.2.3 Type-1 Diabetes Treatment Forecasted Market Size by Region (2025-2030)
2.3 Type-1 Diabetes Treatment Market Dynamics
2.3.1 Type-1 Diabetes Treatment Industry Trends
2.3.2 Type-1 Diabetes Treatment Market Drivers
2.3.3 Type-1 Diabetes Treatment Market Challenges
2.3.4 Type-1 Diabetes Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Type-1 Diabetes Treatment by Players
3.1.1 Global Type-1 Diabetes Treatment Revenue by Players (2019-2024)
3.1.2 Global Type-1 Diabetes Treatment Revenue Market Share by Players (2019-2024)
3.2 Global Type-1 Diabetes Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Type-1 Diabetes Treatment, Ranking by Revenue, 2022 VS 2023 VS 2024
3.4 Global Type-1 Diabetes Treatment Market Concentration Ratio
3.4.1 Global Type-1 Diabetes Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Type-1 Diabetes Treatment Revenue in 2023
3.5 Global Key Players of Type-1 Diabetes Treatment Head office and Area Served
3.6 Global Key Players of Type-1 Diabetes Treatment, Product and Application
3.7 Global Key Players of Type-1 Diabetes Treatment, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Type-1 Diabetes Treatment Breakdown Data by Type
4.1 Global Type-1 Diabetes Treatment Historic Market Size by Type (2019-2024)
4.2 Global Type-1 Diabetes Treatment Forecasted Market Size by Type (2025-2030)
5 Type-1 Diabetes Treatment Breakdown Data by Application
5.1 Global Type-1 Diabetes Treatment Historic Market Size by Application (2019-2024)
5.2 Global Type-1 Diabetes Treatment Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Type-1 Diabetes Treatment Market Size (2019-2030)
6.2 North America Type-1 Diabetes Treatment Market Size by Type
6.2.1 North America Type-1 Diabetes Treatment Market Size by Type (2019-2024)
6.2.2 North America Type-1 Diabetes Treatment Market Size by Type (2025-2030)
6.2.3 North America Type-1 Diabetes Treatment Market Share by Type (2019-2030)
6.3 North America Type-1 Diabetes Treatment Market Size by Application
6.3.1 North America Type-1 Diabetes Treatment Market Size by Application (2019-2024)
6.3.2 North America Type-1 Diabetes Treatment Market Size by Application (2025-2030)
6.3.3 North America Type-1 Diabetes Treatment Market Share by Application (2019-2030)
6.4 North America Type-1 Diabetes Treatment Market Size by Country
6.4.1 North America Type-1 Diabetes Treatment Market Size by Country: 2019 VS 2023 VS 2030
6.4.2 North America Type-1 Diabetes Treatment Market Size by Country (2019-2024)
6.4.3 North America Type-1 Diabetes Treatment Market Size by Country (2025-2030)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Type-1 Diabetes Treatment Market Size (2019-2030)
7.2 Europe Type-1 Diabetes Treatment Market Size by Type
7.2.1 Europe Type-1 Diabetes Treatment Market Size by Type (2019-2024)
7.2.2 Europe Type-1 Diabetes Treatment Market Size by Type (2025-2030)
7.2.3 Europe Type-1 Diabetes Treatment Market Share by Type (2019-2030)
7.3 Europe Type-1 Diabetes Treatment Market Size by Application
7.3.1 Europe Type-1 Diabetes Treatment Market Size by Application (2019-2024)
7.3.2 Europe Type-1 Diabetes Treatment Market Size by Application (2025-2030)
7.3.3 Europe Type-1 Diabetes Treatment Market Share by Application (2019-2030)
7.4 Europe Type-1 Diabetes Treatment Market Size by Country
7.4.1 Europe Type-1 Diabetes Treatment Market Size by Country: 2019 VS 2023 VS 2030
7.4.2 Europe Type-1 Diabetes Treatment Market Size by Country (2019-2024)
7.4.3 Europe Type-1 Diabetes Treatment Market Size by Country (2025-2030)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Type-1 Diabetes Treatment Market Size (2019-2030)
8.2 China Type-1 Diabetes Treatment Market Size by Type
8.2.1 China Type-1 Diabetes Treatment Market Size by Type (2019-2024)
8.2.2 China Type-1 Diabetes Treatment Market Size by Type (2025-2030)
8.2.3 China Type-1 Diabetes Treatment Market Share by Type (2019-2030)
8.3 China Type-1 Diabetes Treatment Market Size by Application
8.3.1 China Type-1 Diabetes Treatment Market Size by Application (2019-2024)
8.3.2 China Type-1 Diabetes Treatment Market Size by Application (2025-2030)
8.3.3 China Type-1 Diabetes Treatment Market Share by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Type-1 Diabetes Treatment Market Size (2019-2030)
9.2 Asia Type-1 Diabetes Treatment Market Size by Type
9.2.1 Asia Type-1 Diabetes Treatment Market Size by Type (2019-2024)
9.2.2 Asia Type-1 Diabetes Treatment Market Size by Type (2025-2030)
9.2.3 Asia Type-1 Diabetes Treatment Market Share by Type (2019-2030)
9.3 Asia Type-1 Diabetes Treatment Market Size by Application
9.3.1 Asia Type-1 Diabetes Treatment Market Size by Application (2019-2024)
9.3.2 Asia Type-1 Diabetes Treatment Market Size by Application (2025-2030)
9.3.3 Asia Type-1 Diabetes Treatment Market Share by Application (2019-2030)
9.4 Asia Type-1 Diabetes Treatment Market Size by Region
9.4.1 Asia Type-1 Diabetes Treatment Market Size by Region: 2019 VS 2023 VS 2030
9.4.2 Asia Type-1 Diabetes Treatment Market Size by Region (2019-2024)
9.4.3 Asia Type-1 Diabetes Treatment Market Size by Region (2025-2030)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Type-1 Diabetes Treatment Market Size (2019-2030)
10.2 Middle East, Africa, and Latin America Type-1 Diabetes Treatment Market Size by Type
10.2.1 Middle East, Africa, and Latin America Type-1 Diabetes Treatment Market Size by Type (2019-2024)
10.2.2 Middle East, Africa, and Latin America Type-1 Diabetes Treatment Market Size by Type (2025-2030)
10.2.3 Middle East, Africa, and Latin America Type-1 Diabetes Treatment Market Share by Type (2019-2030)
10.3 Middle East, Africa, and Latin America Type-1 Diabetes Treatment Market Size by Application
10.3.1 Middle East, Africa, and Latin America Type-1 Diabetes Treatment Market Size by Application (2019-2024)
10.3.2 Middle East, Africa, and Latin America Type-1 Diabetes Treatment Market Size by Application (2025-2030)
10.3.3 Middle East, Africa, and Latin America Type-1 Diabetes Treatment Market Share by Application (2019-2030)
10.4 Middle East, Africa, and Latin America Type-1 Diabetes Treatment Market Size by Country
10.4.1 Middle East, Africa, and Latin America Type-1 Diabetes Treatment Market Size by Country: 2019 VS 2023 VS 2030
10.4.2 Middle East, Africa, and Latin America Type-1 Diabetes Treatment Market Size by Country (2019-2024)
10.4.3 Middle East, Africa, and Latin America Type-1 Diabetes Treatment Market Size by Country (2025-2030)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Astellas Pharma
11.1.1 Astellas Pharma Company Details
11.1.2 Astellas Pharma Business Overview
11.1.3 Astellas Pharma Type-1 Diabetes Treatment Introduction
11.1.4 Astellas Pharma Revenue in Type-1 Diabetes Treatment Business (2019-2024)
11.1.5 Astellas Pharma Recent Developments
11.2 Merck
11.2.1 Merck Company Details
11.2.2 Merck Business Overview
11.2.3 Merck Type-1 Diabetes Treatment Introduction
11.2.4 Merck Revenue in Type-1 Diabetes Treatment Business (2019-2024)
11.2.5 Merck Recent Developments
11.3 Eli Lilly
11.3.1 Eli Lilly Company Details
11.3.2 Eli Lilly Business Overview
11.3.3 Eli Lilly Type-1 Diabetes Treatment Introduction
11.3.4 Eli Lilly Revenue in Type-1 Diabetes Treatment Business (2019-2024)
11.3.5 Eli Lilly Recent Developments
11.4 Novo Nordisk
11.4.1 Novo Nordisk Company Details
11.4.2 Novo Nordisk Business Overview
11.4.3 Novo Nordisk Type-1 Diabetes Treatment Introduction
11.4.4 Novo Nordisk Revenue in Type-1 Diabetes Treatment Business (2019-2024)
11.4.5 Novo Nordisk Recent Developments
11.5 Sanofi
11.5.1 Sanofi Company Details
11.5.2 Sanofi Business Overview
11.5.3 Sanofi Type-1 Diabetes Treatment Introduction
11.5.4 Sanofi Revenue in Type-1 Diabetes Treatment Business (2019-2024)
11.5.5 Sanofi Recent Developments
11.6 AstraZeneca
11.6.1 AstraZeneca Company Details
11.6.2 AstraZeneca Business Overview
11.6.3 AstraZeneca Type-1 Diabetes Treatment Introduction
11.6.4 AstraZeneca Revenue in Type-1 Diabetes Treatment Business (2019-2024)
11.6.5 AstraZeneca Recent Developments
11.7 Boehringer Ingelheim GmbH
11.7.1 Boehringer Ingelheim GmbH Company Details
11.7.2 Boehringer Ingelheim GmbH Business Overview
11.7.3 Boehringer Ingelheim GmbH Type-1 Diabetes Treatment Introduction
11.7.4 Boehringer Ingelheim GmbH Revenue in Type-1 Diabetes Treatment Business (2019-2024)
11.7.5 Boehringer Ingelheim GmbH Recent Developments
11.8 Novartis
11.8.1 Novartis Company Details
11.8.2 Novartis Business Overview
11.8.3 Novartis Type-1 Diabetes Treatment Introduction
11.8.4 Novartis Revenue in Type-1 Diabetes Treatment Business (2019-2024)
11.8.5 Novartis Recent Developments
11.9 Pfizer Inc.
11.9.1 Pfizer Inc. Company Details
11.9.2 Pfizer Inc. Business Overview
11.9.3 Pfizer Inc. Type-1 Diabetes Treatment Introduction
11.9.4 Pfizer Inc. Revenue in Type-1 Diabetes Treatment Business (2019-2024)
11.9.5 Pfizer Inc. Recent Developments
11.10 Abbott Laboratories
11.10.1 Abbott Laboratories Company Details
11.10.2 Abbott Laboratories Business Overview
11.10.3 Abbott Laboratories Type-1 Diabetes Treatment Introduction
11.10.4 Abbott Laboratories Revenue in Type-1 Diabetes Treatment Business (2019-2024)
11.10.5 Abbott Laboratories Recent Developments
11.11 Mannkind Corporation
11.11.1 Mannkind Corporation Company Details
11.11.2 Mannkind Corporation Business Overview
11.11.3 Mannkind Corporation Type-1 Diabetes Treatment Introduction
11.11.4 Mannkind Corporation Revenue in Type-1 Diabetes Treatment Business (2019-2024)
11.11.5 Mannkind Corporation Recent Developments
11.12 Braun Melsungen AG
11.12.1 Braun Melsungen AG Company Details
11.12.2 Braun Melsungen AG Business Overview
11.12.3 Braun Melsungen AG Type-1 Diabetes Treatment Introduction
11.12.4 Braun Melsungen AG Revenue in Type-1 Diabetes Treatment Business (2019-2024)
11.12.5 Braun Melsungen AG Recent Developments
11.13 Macrogenics, Inc.
11.13.1 Macrogenics, Inc. Company Details
11.13.2 Macrogenics, Inc. Business Overview
11.13.3 Macrogenics, Inc. Type-1 Diabetes Treatment Introduction
11.13.4 Macrogenics, Inc. Revenue in Type-1 Diabetes Treatment Business (2019-2024)
11.13.5 Macrogenics, Inc. Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
FEATURED COMPANIES
Astellas Pharma
Merck
Eli Lilly
Sanofi
Astrazeneca plc
Boehringer Ingelheim GmbH
Novartis
Pfizer Inc
Abbott Laboratories
MannKind Corporation
Braun Melsungen AG
MacroGenics Inc
Novo Nordisk
List of Tables
    Table 1. Global Type-1 Diabetes Treatment Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
    Table 2. Key Players of Rapid-Acting Insulin
    Table 3. Key Players of Short-Acting Insulin
    Table 4. Key Players of Others
    Table 5. Global Type-1 Diabetes Treatment Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
    Table 6. Global Type-1 Diabetes Treatment Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 7. Global Type-1 Diabetes Treatment Market Size by Region (2019-2024) & (US$ Million)
    Table 8. Global Type-1 Diabetes Treatment Market Share by Region (2019-2024)
    Table 9. Global Type-1 Diabetes Treatment Forecasted Market Size by Region (2025-2030) & (US$ Million)
    Table 10. Global Type-1 Diabetes Treatment Market Share by Region (2025-2030)
    Table 11. Type-1 Diabetes Treatment Market Trends
    Table 12. Type-1 Diabetes Treatment Market Drivers
    Table 13. Type-1 Diabetes Treatment Market Challenges
    Table 14. Type-1 Diabetes Treatment Market Restraints
    Table 15. Global Type-1 Diabetes Treatment Revenue by Players (2019-2024) & (US$ Million)
    Table 16. Global Type-1 Diabetes Treatment Revenue Share by Players (2019-2024)
    Table 17. Global Top Type-1 Diabetes Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Type-1 Diabetes Treatment as of 2023)
    Table 18. Global Type-1 Diabetes Treatment Industry Ranking 2022 VS 2023 VS 2024
    Table 19. Global 5 Largest Players Market Share by Type-1 Diabetes Treatment Revenue (CR5 and HHI) & (2019-2024)
    Table 20. Global Key Players of Type-1 Diabetes Treatment, Headquarters and Area Served
    Table 21. Global Key Players of Type-1 Diabetes Treatment, Product and Application
    Table 22. Global Key Players of Type-1 Diabetes Treatment, Product and Application
    Table 23. Mergers & Acquisitions, Expansion Plans
    Table 24. Global Type-1 Diabetes Treatment Market Size by Type (2019-2024) & (US$ Million)
    Table 25. Global Type-1 Diabetes Treatment Revenue Market Share by Type (2019-2024)
    Table 26. Global Type-1 Diabetes Treatment Forecasted Market Size by Type (2025-2030) & (US$ Million)
    Table 27. Global Type-1 Diabetes Treatment Revenue Market Share by Type (2025-2030)
    Table 28. Global Type-1 Diabetes Treatment Market Size by Application (2019-2024) & (US$ Million)
    Table 29. Global Type-1 Diabetes Treatment Revenue Share by Application (2019-2024)
    Table 30. Global Type-1 Diabetes Treatment Forecasted Market Size by Application (2025-2030) & (US$ Million)
    Table 31. Global Type-1 Diabetes Treatment Revenue Share by Application (2025-2030)
    Table 32. North America Type-1 Diabetes Treatment Market Size by Type (2019-2024) & (US$ Million)
    Table 33. North America Type-1 Diabetes Treatment Market Size by Type (2025-2030) & (US$ Million)
    Table 34. North America Type-1 Diabetes Treatment Market Size by Application (2019-2024) & (US$ Million)
    Table 35. North America Type-1 Diabetes Treatment Market Size by Application (2025-2030) & (US$ Million)
    Table 36. North America Type-1 Diabetes Treatment Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 37. North America Type-1 Diabetes Treatment Market Size by Country (2019-2024) & (US$ Million)
    Table 38. North America Type-1 Diabetes Treatment Market Size by Country (2025-2030) & (US$ Million)
    Table 39. Europe Type-1 Diabetes Treatment Market Size by Type (2019-2024) & (US$ Million)
    Table 40. Europe Type-1 Diabetes Treatment Market Size by Type (2025-2030) & (US$ Million)
    Table 41. Europe Type-1 Diabetes Treatment Market Size by Application (2019-2024) & (US$ Million)
    Table 42. Europe Type-1 Diabetes Treatment Market Size by Application (2025-2030) & (US$ Million)
    Table 43. Europe Type-1 Diabetes Treatment Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 44. Europe Type-1 Diabetes Treatment Market Size by Country (2019-2024) & (US$ Million)
    Table 45. Europe Type-1 Diabetes Treatment Market Size by Country (2025-2030) & (US$ Million)
    Table 46. China Type-1 Diabetes Treatment Market Size by Type (2019-2024) & (US$ Million)
    Table 47. China Type-1 Diabetes Treatment Market Size by Type (2025-2030) & (US$ Million)
    Table 48. China Type-1 Diabetes Treatment Market Size by Application (2019-2024) & (US$ Million)
    Table 49. China Type-1 Diabetes Treatment Market Size by Application (2025-2030) & (US$ Million)
    Table 50. Asia Type-1 Diabetes Treatment Market Size by Type (2019-2024) & (US$ Million)
    Table 51. Asia Type-1 Diabetes Treatment Market Size by Type (2025-2030) & (US$ Million)
    Table 52. Asia Type-1 Diabetes Treatment Market Size by Application (2019-2024) & (US$ Million)
    Table 53. Asia Type-1 Diabetes Treatment Market Size by Application (2025-2030) & (US$ Million)
    Table 54. Asia Type-1 Diabetes Treatment Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 55. Asia Type-1 Diabetes Treatment Market Size by Region (2019-2024) & (US$ Million)
    Table 56. Asia Type-1 Diabetes Treatment Market Size by Region (2025-2030) & (US$ Million)
    Table 57. Middle East, Africa, and Latin America Type-1 Diabetes Treatment Market Size by Type (2019-2024) & (US$ Million)
    Table 58. Middle East, Africa, and Latin America Type-1 Diabetes Treatment Market Size by Type (2025-2030) & (US$ Million)
    Table 59. Middle East, Africa, and Latin America Type-1 Diabetes Treatment Market Size by Application (2019-2024) & (US$ Million)
    Table 60. Middle East, Africa, and Latin America Type-1 Diabetes Treatment Market Size by Application (2025-2030) & (US$ Million)
    Table 61. Middle East, Africa, and Latin America Type-1 Diabetes Treatment Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 62. Middle East, Africa, and Latin America Type-1 Diabetes Treatment Market Size by Country (2019-2024) & (US$ Million)
    Table 63. Middle East, Africa, and Latin America Type-1 Diabetes Treatment Market Size by Country (2025-2030) & (US$ Million)
    Table 64. Astellas Pharma Company Details
    Table 65. Astellas Pharma Business Overview
    Table 66. Astellas Pharma Type-1 Diabetes Treatment Product
    Table 67. Astellas Pharma Revenue in Type-1 Diabetes Treatment Business (2019-2024) & (US$ Million)
    Table 68. Astellas Pharma Recent Developments
    Table 69. Merck Company Details
    Table 70. Merck Business Overview
    Table 71. Merck Type-1 Diabetes Treatment Product
    Table 72. Merck Revenue in Type-1 Diabetes Treatment Business (2019-2024) & (US$ Million)
    Table 73. Merck Recent Developments
    Table 74. Eli Lilly Company Details
    Table 75. Eli Lilly Business Overview
    Table 76. Eli Lilly Type-1 Diabetes Treatment Product
    Table 77. Eli Lilly Revenue in Type-1 Diabetes Treatment Business (2019-2024) & (US$ Million)
    Table 78. Eli Lilly Recent Developments
    Table 79. Novo Nordisk Company Details
    Table 80. Novo Nordisk Business Overview
    Table 81. Novo Nordisk Type-1 Diabetes Treatment Product
    Table 82. Novo Nordisk Revenue in Type-1 Diabetes Treatment Business (2019-2024) & (US$ Million)
    Table 83. Novo Nordisk Recent Developments
    Table 84. Sanofi Company Details
    Table 85. Sanofi Business Overview
    Table 86. Sanofi Type-1 Diabetes Treatment Product
    Table 87. Sanofi Revenue in Type-1 Diabetes Treatment Business (2019-2024) & (US$ Million)
    Table 88. Sanofi Recent Developments
    Table 89. AstraZeneca Company Details
    Table 90. AstraZeneca Business Overview
    Table 91. AstraZeneca Type-1 Diabetes Treatment Product
    Table 92. AstraZeneca Revenue in Type-1 Diabetes Treatment Business (2019-2024) & (US$ Million)
    Table 93. AstraZeneca Recent Developments
    Table 94. Boehringer Ingelheim GmbH Company Details
    Table 95. Boehringer Ingelheim GmbH Business Overview
    Table 96. Boehringer Ingelheim GmbH Type-1 Diabetes Treatment Product
    Table 97. Boehringer Ingelheim GmbH Revenue in Type-1 Diabetes Treatment Business (2019-2024) & (US$ Million)
    Table 98. Boehringer Ingelheim GmbH Recent Developments
    Table 99. Novartis Company Details
    Table 100. Novartis Business Overview
    Table 101. Novartis Type-1 Diabetes Treatment Product
    Table 102. Novartis Revenue in Type-1 Diabetes Treatment Business (2019-2024) & (US$ Million)
    Table 103. Novartis Recent Developments
    Table 104. Pfizer Inc. Company Details
    Table 105. Pfizer Inc. Business Overview
    Table 106. Pfizer Inc. Type-1 Diabetes Treatment Product
    Table 107. Pfizer Inc. Revenue in Type-1 Diabetes Treatment Business (2019-2024) & (US$ Million)
    Table 108. Pfizer Inc. Recent Developments
    Table 109. Abbott Laboratories Company Details
    Table 110. Abbott Laboratories Business Overview
    Table 111. Abbott Laboratories Type-1 Diabetes Treatment Product
    Table 112. Abbott Laboratories Revenue in Type-1 Diabetes Treatment Business (2019-2024) & (US$ Million)
    Table 113. Abbott Laboratories Recent Developments
    Table 114. Mannkind Corporation Company Details
    Table 115. Mannkind Corporation Business Overview
    Table 116. Mannkind Corporation Type-1 Diabetes Treatment Product
    Table 117. Mannkind Corporation Revenue in Type-1 Diabetes Treatment Business (2019-2024) & (US$ Million)
    Table 118. Mannkind Corporation Recent Developments
    Table 119. Braun Melsungen AG Company Details
    Table 120. Braun Melsungen AG Business Overview
    Table 121. Braun Melsungen AG Type-1 Diabetes Treatment Product
    Table 122. Braun Melsungen AG Revenue in Type-1 Diabetes Treatment Business (2019-2024) & (US$ Million)
    Table 123. Braun Melsungen AG Recent Developments
    Table 124. Macrogenics, Inc. Company Details
    Table 125. Macrogenics, Inc. Business Overview
    Table 126. Macrogenics, Inc. Type-1 Diabetes Treatment Product
    Table 127. Macrogenics, Inc. Revenue in Type-1 Diabetes Treatment Business (2019-2024) & (US$ Million)
    Table 128. Macrogenics, Inc. Recent Developments
    Table 129. Research Programs/Design for This Report
    Table 130. Key Data Information from Secondary Sources
    Table 131. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Type-1 Diabetes Treatment Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 2. Global Type-1 Diabetes Treatment Market Share by Type: 2023 VS 2030
    Figure 3. Rapid-Acting Insulin Features
    Figure 4. Short-Acting Insulin Features
    Figure 5. Others Features
    Figure 6. Global Type-1 Diabetes Treatment Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 7. Global Type-1 Diabetes Treatment Market Share by Application: 2023 VS 2030
    Figure 8. Hospitals & Clinics Case Studies
    Figure 9. Academic & Research Institutes Case Studies
    Figure 10. Type-1 Diabetes Treatment Report Years Considered
    Figure 11. Global Type-1 Diabetes Treatment Market Size (US$ Million), Year-over-Year: 2019-2030
    Figure 12. Global Type-1 Diabetes Treatment Market Size, (US$ Million), 2019 VS 2023 VS 2030
    Figure 13. Global Type-1 Diabetes Treatment Market Share by Region: 2023 VS 2030
    Figure 14. Global Type-1 Diabetes Treatment Market Share by Players in 2023
    Figure 15. Global Top Type-1 Diabetes Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Type-1 Diabetes Treatment as of 2023)
    Figure 16. The Top 10 and 5 Players Market Share by Type-1 Diabetes Treatment Revenue in 2023
    Figure 17. North America Type-1 Diabetes Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 18. North America Type-1 Diabetes Treatment Market Share by Type (2019-2030)
    Figure 19. North America Type-1 Diabetes Treatment Market Share by Application (2019-2030)
    Figure 20. North America Type-1 Diabetes Treatment Market Share by Country (2019-2030)
    Figure 21. United States Type-1 Diabetes Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 22. Canada Type-1 Diabetes Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 23. Europe Type-1 Diabetes Treatment Market Size YoY (2019-2030) & (US$ Million)
    Figure 24. Europe Type-1 Diabetes Treatment Market Share by Type (2019-2030)
    Figure 25. Europe Type-1 Diabetes Treatment Market Share by Application (2019-2030)
    Figure 26. Europe Type-1 Diabetes Treatment Market Share by Country (2019-2030)
    Figure 27. Germany Type-1 Diabetes Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 28. France Type-1 Diabetes Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 29. U.K. Type-1 Diabetes Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 30. Italy Type-1 Diabetes Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 31. Russia Type-1 Diabetes Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 32. Nordic Countries Type-1 Diabetes Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 33. China Type-1 Diabetes Treatment Market Size YoY (2019-2030) & (US$ Million)
    Figure 34. China Type-1 Diabetes Treatment Market Share by Type (2019-2030)
    Figure 35. China Type-1 Diabetes Treatment Market Share by Application (2019-2030)
    Figure 36. Asia Type-1 Diabetes Treatment Market Size YoY (2019-2030) & (US$ Million)
    Figure 37. Asia Type-1 Diabetes Treatment Market Share by Type (2019-2030)
    Figure 38. Asia Type-1 Diabetes Treatment Market Share by Application (2019-2030)
    Figure 39. Asia Type-1 Diabetes Treatment Market Share by Region (2019-2030)
    Figure 40. Japan Type-1 Diabetes Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 41. South Korea Type-1 Diabetes Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 42. China Taiwan Type-1 Diabetes Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 43. Southeast Asia Type-1 Diabetes Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 44. India Type-1 Diabetes Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 45. Australia Type-1 Diabetes Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 46. Middle East, Africa, and Latin America Type-1 Diabetes Treatment Market Size YoY (2019-2030) & (US$ Million)
    Figure 47. Middle East, Africa, and Latin America Type-1 Diabetes Treatment Market Share by Type (2019-2030)
    Figure 48. Middle East, Africa, and Latin America Type-1 Diabetes Treatment Market Share by Application (2019-2030)
    Figure 49. Middle East, Africa, and Latin America Type-1 Diabetes Treatment Market Share by Country (2019-2030)
    Figure 50. Brazil Type-1 Diabetes Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 51. Mexico Type-1 Diabetes Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 52. Turkey Type-1 Diabetes Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 53. Saudi Arabia Type-1 Diabetes Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 54. Israel Type-1 Diabetes Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 55. GCC Countries Type-1 Diabetes Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 56. Astellas Pharma Revenue Growth Rate in Type-1 Diabetes Treatment Business (2019-2024)
    Figure 57. Merck Revenue Growth Rate in Type-1 Diabetes Treatment Business (2019-2024)
    Figure 58. Eli Lilly Revenue Growth Rate in Type-1 Diabetes Treatment Business (2019-2024)
    Figure 59. Novo Nordisk Revenue Growth Rate in Type-1 Diabetes Treatment Business (2019-2024)
    Figure 60. Sanofi Revenue Growth Rate in Type-1 Diabetes Treatment Business (2019-2024)
    Figure 61. AstraZeneca Revenue Growth Rate in Type-1 Diabetes Treatment Business (2019-2024)
    Figure 62. Boehringer Ingelheim GmbH Revenue Growth Rate in Type-1 Diabetes Treatment Business (2019-2024)
    Figure 63. Novartis Revenue Growth Rate in Type-1 Diabetes Treatment Business (2019-2024)
    Figure 64. Pfizer Inc. Revenue Growth Rate in Type-1 Diabetes Treatment Business (2019-2024)
    Figure 65. Abbott Laboratories Revenue Growth Rate in Type-1 Diabetes Treatment Business (2019-2024)
    Figure 66. Mannkind Corporation Revenue Growth Rate in Type-1 Diabetes Treatment Business (2019-2024)
    Figure 67. Braun Melsungen AG Revenue Growth Rate in Type-1 Diabetes Treatment Business (2019-2024)
    Figure 68. Macrogenics, Inc. Revenue Growth Rate in Type-1 Diabetes Treatment Business (2019-2024)
    Figure 69. Bottom-up and Top-down Approaches for This Report
    Figure 70. Data Triangulation
    Figure 71. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Leap India

SIMILAR REPORTS

Global Diabetes Therapeutics and Diagnostics Market Insights Forecast to 2030
Global Diabetes Mellitus Treatment Market Insights Forecast to 2030
Diabetes Treatment Device Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Diabetes Care Drugs Market Insights Forecast to 2030
Global Hypoglycemic Drugs Market Insights Forecast to 2030
Global Diabetes Management Equipment Market Research Report 2024
Global Diabetes Treatment Devices Market Research Report 2024
Global Diabetic Ulcers Treatment Market Insights Forecast to 2030
Global Diabetes Drugs Sales Market Report Competitive Analysis and Regional Opportunities 2025 2031
Diabetes Devices and Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Diabetes Care Service Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Diabetic Neurological Disorder Therapeutic Drug Market Insights Forecast to 2030
Diabetes Treatment Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Diabetic Gastroparesis Treatment Products Market Insights Forecast to 2030
Diabetes Management Software Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Diabetes Software Market Insights Forecast to 2030
Global Diabetes Associated Ophthalmic Treatment Market Research Report 2025
Global Diabetes Management Products Market Insights Forecast to 2030
Gestational Diabetes Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Digital Diabetes Care Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions